(226 days)
Not Found
No
The summary describes a standard sterilization device with a factory-programmed control system, not mentioning any AI or ML capabilities.
No.
The document describes a sterilizer intended for medical devices, not a device used for therapy on humans.
No
This device is a sterilizer, meaning it cleans and disinfects medical devices, making them ready for use. It is not used to diagnose a patient's condition or disease.
No
The device is a physical sterilizer that uses hydrogen peroxide and ozone to sterilize medical devices. It is a piece of hardware with a control system, not a software-only device.
Based on the provided text, the STERIZONE® VP4 Sterilizer is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is "terminal sterilization of cleaned, rinsed, and dried metal and non-metal reusable medical devices in health care facilities." This describes a process for making medical devices sterile for use on or in the human body, not for examining specimens from the human body.
- Device Description: The description details a sterilization chamber, the sterilization process using hydrogen peroxide and ozone, and compatible packaging materials. This aligns with a sterilization device, not an IVD.
- Lack of IVD Characteristics: The text does not mention any of the typical characteristics of an IVD, such as:
- Analyzing human specimens (blood, urine, tissue, etc.)
- Providing information about a patient's health status, diagnosis, or treatment
- Using reagents or assays for testing
- Outputting diagnostic results
The STERIZONE® VP4 Sterilizer is a device used to prepare medical instruments for use, which is a crucial step in healthcare but distinct from the function of an IVD.
N/A
Intended Use / Indications for Use
The STERIZONE® VP4 Sterilizer is intended for use in terminal sterilization of cleaned, rinsed, and dried metal and non-metal reusable medical devices in health care facilities.
The single pre-set cycle of the STERIZONE® VP4 Sterilizer uses hydrogen peroxide and ozone. The injection of vaporized hydrogen peroxide is followed by the injection of ozone, which reacts with residual hydrogen peroxide to form hydroxyl radicals.
Sterilization efficacy was demonstrated using a representative sample of one or more device types and packaging, in seven separate validation loads, as described in Table 1. The load to be processed should be maintained between 20℃ to 26℃ (68°F to 78°F). Total load weight shall not exceed 75 lbs. inclusive of the containers/packaging weight but excluding the 25 lbs loading rack.
Product codes (comma separated list FDA assigned to the subject device)
PJJ
Device Description
The STERIZONE® VP4 Sterilization chamber has a capacity of 4.4 cu. ft. (125 liters). It requires oxygen (94% pure and greater), electricity and the 125-280 Solution™ containing 50% hydrogen peroxide by weight. Both hydrogen peroxide and ozone are used in a multiphase process.
The STERIZONE® VP4 Sterilizer is equipped with a factory-programmed control system offering a unique sterilization cycle.
Processed medical instruments are ready to use immediately after the cycle ends; no aeration is required.
Polypropylene non-woven wrapping material, non-woven polyethylene (Tyvek™) with polyester/LDPE transparent film pouches, and vaporized hydrogen peroxide compatible aluminium containers using disposable polypropylene filters, are used as packaging for medical devices to be sterilized. Plastic and metal trays are also suitable packaging means when combined with polypropylene wraps.
A self-contained biological indicator containing spores of G. stearothermophilus, incorporated into a test pack, is recommended to monitor cycle performance.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
health care facilities.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The STERIZONE® VP4 Sterilizer performance validation testing was performed using the « overkill » approach to demonstrate the effectiveness of the process. Testing on directly inoculated medical devices was conducted employing half-cycle to demonstrate achievement of a sterility assurance level (SAL) of 106 at the complete cycle.
This process has been demonstrated to be effective for terminal sterilization of packaged reusable medical devices.
Safety and Effectiveness testing performed for the STERIZONE® VP4 Sterilizer are summarized in Table 3.
- Effective to sterilize medical devices inoculated with 106 microorganism at the half-cycle conditions (Half-cycle validation testing) - Met requirements
- Effective to sterilize medical devices inoculated with 106 microorganism in the presence of organic and inorganic matter at the complete cycle (Simulated-use testing) - Met requirements
- Sterilize medical devices in real life conditions (In-use testing) - Met requirements
- Pass the AOAC Sporicidal Screening Test - Met requirements
- Sterilize effectively on non-woven polyethylene sterilization pouches, rigid aluminum containers and wrapped trays - Met requirements
- Sterilization efficacy is repeatable - Met requirements
- Sterilant is not toxic for users and patients - Met requirements
- Most of the materials used in the manufacturing of medical devices are compatible with the hydrogen peroxide-ozone sterilization process - Met requirements
- Sterilizer complies with electrical safety standards UL 61010-1, CAN/CSA 61010-1, EN/IEC 61010-1 and 61010-2-040 - Met requirements
- Sterilizer complies with EMI/EMC requirements of FCC 47CFR, part 18, subpart B, and IEC 613261 - Met requirements
- A Fault Tree Analysis and Mitigation (FTA-MIT) analysis have been preformed on the sterilizer and potential hazards were identified and mitigations were implemented among the control software safeties and design features - Met requirements
- A Failure Mode Effects and Criticality Analysis (FMECA) was done for each component of the sterilizer and safeties were included in the design of the device according to the findings of this study (built-in safeties) - Met requirements
- The amount of hydrogen peroxide and ozone remaining on containers and pouches immediately after cycle is not significant - Met requirements
- There are no toxic residue or by-products residues remaining in/on medical product after the sterilization cycle is completed. After the cycle is completed, medical devices are cool to touch and ready to use immediately (no aeration is required) - Met requirements
- The sterilization process is safe from an occupational safety point of view - Met requirements
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
STERRAD® 100NX® Sterilizer with DUO Cycle (K111377), Amsco® V-PRO® maX Low Temperature Sterilization System (K131120)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.6860 Ethylene oxide gas sterilizer.
(a)
Identification. An ethylene gas sterilizer is a nonportable device intended for use by a health care provider that uses ethylene oxide (ETO) to sterilize medical products.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around an emblem. The emblem consists of a stylized human figure with three faces, representing the department's focus on health and human well-being.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 17, 2014
TSO3 Inc. C/O Thomas Richards, Ph.D. Consultant IM3, Inc. 512F NE 81st Street, Suite110 Vancouver, WA 98665
Re: K141163
Trade/Device Name: STERIZONE® VP4 Sterilizer Regulation Number: 21 CFR 880.6860 Regulation Name: Ethylene Oxide Gas Sterilizer Regulatory Class: II Product Code: PJJ Dated: December 8, 2014 Received: December 10, 2014
Dear Dr. Richards:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Dr. Richards
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tejashri Purohit-Sheth, M.D.
Tejashri Purohit-Sheth, M.D. Clinical Deputy Director DAGRID/ODE/CDRH FOR
Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
2
Indications for Use
510(k) Number (if known) K141163
Device Name
STERIZONE® VP4 Sterilizer
Indications for Use (Describe)
The STERIZONE® VP4 Sterilizer is intended for use in terminal sterilization of cleaned, rinsed, and dried metal and non-metal reusable medical devices in health care facilities.
The single pre-set cycle of the STERIZONE® VP4 Sterilizer uses hydrogen peroxide and ozone. The injection of vaporized hydrogen peroxide is followed by the injection of ozone, which reacts with residual hydrogen peroxide to form hydroxyl radicals.
Sterilization efficacy was demonstrated using a representative sample of one or more device types and packaging, in seven separate validation loads, as described in Table 1. The load to be processed should be maintained between 20℃ to 26℃ (68°F to 78°F). Total load weight shall not exceed 75 lbs. inclusive of the containers/packaging weight but excluding the 25 lbs loading rack.
| Validation
load # | Load description | Load weight1
1Excluding the 25
lb loading rack |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------|
| 1 | Validation load #1 consisted of general medical instruments, representing the following geometries: Clamp Serrated surface Box-lock Handle Button Pivot hinge Stopcock Type of packaging used: wrapped plastic tray, including silicone mats and brackets, and Pouch
General medical instruments were spread out over three trays, six pouches and one wrapped instrument. | 11 lb |
| 2 | Validation load #2 consisted of general medical instruments, representing the following geometries: Gliding mechanism Hinges and screws Serrated surface Luer-lock Spring Rigid non-lumen scopes Type of packaging used: wrapped plastic and aluminum tray, including silicone mats and brackets, rigid aluminum container and Pouch
General medical instruments were spread out over one container, three trays, and six pouches. | 20 lb |
Table 1. Description of the seven validation loads
3
| Validation
load # | Load description | Load weight1
Excluding the 25
Ib loading rack1 |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------|
| 3 | Validation load #3 consisted of three single channel flexible endoscopes
(Ureteroscope) with inside diameter of 1.0 mm and length of 850 mm, packaged
individually in wrapped trays or containers, including appropriate silicone brackets
or mats. Eight general medical instruments, each packaged in a pouch, were added. | 23 lb |
| 4 | Validation load #4 consisted of up to 15 rigid or semi-rigid channeled instruments in
the presence of other packaged medical devices. Three double channel semi-rigid
endoscopes (ureteroscope - $0.7 mm \times 500 mm$ and $1.1 mm \times 500 mm$ ) were
packaged individually in wrapped trays or containers including appropriate silicone
brackets or mats. Additional rigid channeled instruments or stainless steel rigid
lumens were added to each package. Two additional general medical instruments,
each packaged in a pouch, were added. | 19 lb |
| 5 | Validation load #5 consisted in two single channel flexible endoscopes; one
Ureteroscope with inside diameter of 1.0 mm and length of 850 mm, and a
Bronchoscope with inside diameter of 1.8 mm and length of 830 mm, and one
double channel semi- rigid endoscope (ureteroscope - $0.7 mm \times 500 mm$ and $1.1 mm \times 500 mm$ ), packaged individually in wrapped trays or containers including
appropriate silicone brackets or mats. No additional item was added. | 21 lb |
| 6 | Validation load #6 consisted of general medical instruments, representing the
following geometries:
• Distal end (swivel parts)
• Hinge with screw
• Cannula
General medical instruments packaged in one aluminum sterilization container. | 9 lb |
| 7 | Validation load #7 consisted of general medical instruments, representing the
following geometries:
• Box-lock hinge
• Pivot hinge
• Luer-lock
General medical instruments, spread out over three aluminum sterilization
containers, each weighting 25 lb. | 75 lb |
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/0 description: The image shows a chemical structure. The structure contains the letters 'Ts' on the left side. To the right of 'Ts' is a chemical structure with a benzene ring and three oxygen atoms. The number '3' is located at the bottom right of the structure.
510(k) Summary
Applicant's Name and Address
TSO3 Inc. 2505, avenue Dalton Quebec, QC G1P 3S5 Canada
Contact Person, Telephone, FAX
Marc Chaunet, Director of Regulatory Affairs Phone: (418) 653-0003 ext. 242 Fax: (418) 653-5726 E-mail: mchaunet@tso3.com
U.S. Contact
IM3, Inc. Contact: Thomas Richards, Ph.D. Phone: 503-415-0250 Email: tomami20x@gmail.com
Summary Date December 12, 2014
Trade Name STERIZONE® VP4 Sterilizer
Common Name
Vaporized Hydrogen Peroxide Sterilizer
Classification Name
Sterilizer, Chemical Class II (as per 21CFR, part 880.6860 equivalent device) Product code: PJJ
Legally Marketed Equivalent Device Name(s)
STERRAD® 100NX® Sterilizer with DUO Cycle (K111377) Amsco® V-PRO® maX Low Temperature Sterilization System (K131120)
5
Image /page/5/Picture/0 description: The image shows a chemical structure diagram. The diagram depicts a central sulfur atom (S) bonded to three oxygen atoms (O), forming an SO3 group. The 'T' next to the sulfur atom is not clearly defined in the image, but it may represent a functional group or a placeholder for a larger molecule. The overall structure suggests a sulfur-containing compound, possibly an intermediate or a fragment of a larger molecule.
Process description
The STERIZONE® VP4 Sterilizer offers a single pre-set sterilization cycle designed for the sterilization of general instruments, single channel flexible endoscopes, rigid and semi-rigid channeled devices including single channel and double channel rigid endoscopes.
The STERIZONE® VP4 Sterilizer uses dual sterilants, vaporized hydrogen peroxide (H202) and ozone (O3), in a multiphase process.
Upon loading the medical devices into the sterilization chamber and closure of the door, the chamber is subjected to a vacuum of 1 Torr (referred to as pre-conditioning step). The first cycle phase (Phase 1) is initiated with the Dynamic H2O2 exposure step. During this step, a 50 weight-percent hydrogen peroxide solution (referred to as 125-280 Solution™) is injected at a fixed injection rate in vapor form into the sterilization chamber through a continuous micropulsed injection until a differential pressure set point of 19 Torr is reached (i.e., the actual chamber pressure is 20 Torr, less the initial vacuum of 1 Torr, which is equivalent to a "differential pressure" or "AP" of 19 Torr). The total amount of hydrogen peroxide introduced into the sterilization chamber and thus the duration of the injection varies depending on load composition (e.g. surface area), weight and temperature.
The second step of the cycle phase is the H2O2 Reduction Step. During this step, a set concentration of ozone is injected into the chamber and reacts with residual hydrogen peroxide to form hydroxyl radicals.
During the second cycle phase (Phase 2), the same sequence is repeated, including the Dynamic H2O2 exposure and H2O2 reduction steps. The full Cycle is then completed with an evacuation and ventilation, through a catalytic converter, to the atmosphere, at which point the chamber door can be safely opened.
The cycle process parameters are summarized in Table 1.
6
| Hydrogen peroxide exposure | Ozone exposure | ||||||
|---|---|---|---|---|---|---|---|
| Hydrogen | |||||||
| peroxide solution | Chamber | ||||||
| differential | |||||||
| pressure | |||||||
| set point | Time | Sterilant | |||||
| injected | Vaporizer / | ||||||
| Chamber | |||||||
| temperature | O3 | ||||||
| injection | O3 | ||||||
| dwell | Nb of | ||||||
| phases | |||||||
| 125-280 Solution™ | |||||||
| (H2O2 50 wt%) | 19 Torr | 210-600 | |||||
| sec* | 8.4-24 g* | 120°C / | |||||
| 41 ± 3°C | 2 mg/L | 5 min | 2 |
Table 1. STERIZONE® VP4 Sterilizer – Cycle process parameters
- Vaporized hydrogen peroxide injection/exposure time (Dynamic H2O2 exposure step) varies with load composition and conditions. The quantity of vaporized hydrogen peroxide injected is directly related to the time required to reach a pressure differential of 19 Torr in the chamber, for load temperature ranging from 20℃ to 26℃. If the H2O2 injection time is less than 210 seconds, or greater than 600 seconds, the cycle will abort.
Intended Use
The STERIZONE® VP4 Sterilizer is intended for use in terminal sterilization of cleaned, rinsed, and dried metal and non-metal reusable medical devices in health care facilities.
The single pre-set cycle of the STERIZONE® VP4 Sterilizer uses dual sterilants hydrogen peroxide and ozone. The injection of vaporized hydrogen peroxide is followed by the injection of ozone, which reacts with residual hydrogen peroxide to form hydroxyl radicals.
Sterilization efficacy was demonstrated using a representative sample of one or more device types and packaging, in seven separate validation loads, as described in Table 2. The load to be processed should be maintained between 20°C to 26°C (68°F to 78°F). Total load weight shall not exceed 75 lbs, inclusive of the containers/packaging weight but excluding the 25 lbs loading rack.
7
Image /page/7/Picture/0 description: The image shows a chemical structure diagram. The diagram depicts a molecule with the abbreviation 'Ts' on the left, followed by a sulfur atom (S) connected to three oxygen atoms (O). The oxygen atoms are arranged in a triangular shape around the sulfur atom, suggesting a sulfonate group. The 'Ts' likely represents a tosyl group, a common protecting group in organic chemistry.
| Validation
load # | Load description | Load
weight1 |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------|
| | | 1Excluding
the 25 lb
loading
rack |
| 1 | Validation load #1 consisted of general medical instruments, representing the
following geometries:
Clamp Serrated surface Box-lock Handle Button Pivot hinge Stopcock Type of packaging used: wrapped plastic tray, including silicone mats and
brackets, and Pouch
General medical instruments were spread out over three trays, six pouches and one
wrapped instrument. | 11 lb |
| 2 | Validation load #2 consisted of general medical instruments, representing the
following geometries:
Gliding mechanism Hinges and screws Serrated surface Luer-lock Spring Rigid non-lumen scopes Type of packaging used: wrapped plastic and aluminum tray, including silicone mats
and brackets, rigid aluminum container and Pouch
General medical instruments were spread out over one container, three trays, and six
pouches. | 20 lb |
| 3 | Validation load #3 consisted of three single channel flexible endoscopes
(Ureteroscope) with inside diameter of 1.0 mm and length of 850 mm, packaged
individually in wrapped trays or containers, including appropriate silicone
brackets or mats. Eight general medical instruments, each packaged in a pouch,
were added. | 23 lb |
| 4 | Validation load #4 consisted of up to 15 rigid or semi-rigid channeled
instruments in the presence of other packaged medical devices. Three double
channel semi-rigid endoscopes (ureteroscope – 0.7 mm × 500 mm and 1.1 mm ×
500 mm) were packaged individually in wrapped trays or containers including
appropriate silicone brackets or mats. Additional rigid channeled instruments or
stainless steel rigid lumens were added to each package. Two additional general
medical instruments, each packaged in a pouch, were added. | 19 lb |
| 5 | Validation load #5 consisted in two single channel flexible endoscopes; one
Ureteroscope with inside diameter of 1.0 mm and length of 850 mm, and a
Bronchoscope with inside diameter of 1.8 mm and length of 830 mm, and one
double channel semi- rigid endoscope (ureteroscope - 0.7 mm × 500 mm and
1.1 mm × 500 mm), packaged individually in wrapped trays or containers
including appropriate silicone brackets or mats. No additional item was added. | 21 lb |
| Validation
load # | Load description | Load
weight1
1Excluding
the 25 lb
loading
rack |
| 6 | Validation load #6 consisted of general medical instruments, representing the
following geometries:
• Distal end (swivel parts)
• Hinge with screw
• Cannula
General medical instruments packaged in one aluminum sterilization container. | 9 lb |
| 7 | Validation load #7 consisted of general medical instruments, representing the
following geometries:
• Box-lock hinge
• Pivot hinge
• Luer-lock
General medical instruments, spread out over three aluminum sterilization
containers, each weighting 25 lb. | 75 lb |
Table 2. Description of the seven validation loads
8
Description of Device
The STERIZONE® VP4 Sterilization chamber has a capacity of 4.4 cu. ft. (125 liters). It requires oxygen (94% pure and greater), electricity and the 125-280 Solution™ containing 50% hydrogen peroxide by weight. Both hydrogen peroxide and ozone are used in a multiphase process.
The STERIZONE® VP4 Sterilizer is equipped with a factory-programmed control system offering a unique sterilization cycle.
Processed medical instruments are ready to use immediately after the cycle ends; no aeration is required.
Polypropylene non-woven wrapping material, non-woven polyethylene (Tyvek™) with polyester/LDPE transparent film pouches, and vaporized hydrogen peroxide compatible aluminium containers using disposable polypropylene filters, are used as packaging for medical devices to be sterilized. Plastic and metal trays are also suitable packaging means when combined with polypropylene wraps.
A self-contained biological indicator containing spores of G. stearothermophilus, incorporated into a test pack, is recommended to monitor cycle performance.
9
The STERIZONE® VP4 Sterilizer could be installed as a free standing unit or recessed behind the wall.
No exhaust gas ventilation duct is required as long as the room is adequately ventilated.
Effectiveness
The STERIZONE® VP4 Sterilizer performance validation testing was performed using the « overkill » approach to demonstrate the effectiveness of the process. Testing on directly inoculated medical devices was conducted employing half-cycle to demonstrate achievement of a sterility assurance level (SAL) of 106 at the complete cycle.
This process has been demonstrated to be effective for terminal sterilization of packaged reusable medical devices.
Safety
The STERIZONE® VP4 Sterilizer has been designed, constructed and tested to meet the safety and performance requirements of various North American safety codes and standards. The STERIZONE® VP4 Sterilizer complies with the applicable portions of the following standards:
- Canadian Standard Association (CSA) Standard C22.2 No 61010-1: 2004 .
- Underwriters Laboratory Standard UL 61010-1: 2004
- Federal Communication Commission (FCC) Part 18 / EN 55011 ●
- International Electrotechnical Commission (IEC) Standard IEC 61326: 2012
- . International Electrotechnical Commission (IEC) Standard 61010-1 :2001, 61010-2-040: 2005
A Fault Tree Analysis and Mitigation (FTA-MIT) and a Failure Mode Effects and Criticality Analysis (FMECA) has been conducted on the entire system of the STERIZONE® VP4 Sterilizer to ensure safety features and control redundancies have been implemented in the design and will be maintained during the manufacturing, installation, maintenance and servicing of the sterilizers.
10
Image /page/10/Picture/0 description: The image shows a chemical structure diagram. The diagram depicts a TsO3 molecule, with 'Ts' representing a tosyl group attached to a sulfur atom (S). The sulfur atom is bonded to three oxygen atoms (O3). The structure is presented in a simplified, two-dimensional format, commonly used in chemical notation.
To ensure optimum performance, the user must ensure the materials, instruments and devices to be sterilized are thoroughly cleaned and dried, that the instrument manufacturer's instructions are followed, and that each sterilization load is monitored with biological and chemical sterilization process indicators.
The software controls of the STERIZONE® VP4 Sterilizer have been designed providing safeguards that only intended operating cycles function to completion. Process parameters falling outside acceptable range will cancel the cycle and provide appropriate information identifying the source of the problem detected.
The following Table 3 summarizes the safety and effectiveness testing performed for the STERIZONE® VP4 Sterilizer.
11
Table 3. Summary of Safety and Effectiveness testing performed for the STERIZONE® VP4 Sterilizer
| Performance Requirements for Effectiveness | Results | |
|---|---|---|
| 1 | Effective to sterilize medical devices inoculated with 106 microorganism at the half-cycle conditions (Half-cycle validation testing) | Met requirements |
| 2 | Effective to sterilize medical devices inoculated with 106 microorganism in the presence of organic and inorganic matter at the complete cycle (Simulated-use testing) | Met requirements |
| 3 | Sterilize medical devices in real life conditions (In-use testing) | Met requirements |
| 4 | Pass the AOAC Sporicidal Screening Test | Met requirements |
| 5 | Sterilize effectively on non-woven polyethylene sterilization pouches, rigid aluminum containers and wrapped trays | Met requirements |
| 6 | Sterilization efficacy is repeatable | Met requirements |
| Performance Requirements for Safety | ||
| 1 | Sterilant is not toxic for users and patients | Met requirements |
| 2 | Most of the materials used in the manufacturing of medical devices are compatible with the hydrogen peroxide-ozone sterilization process | Met requirements |
| 3 | Sterilizer complies with electrical safety standards UL 61010-1, CAN/CSA 61010-1, EN/IEC 61010-1 and 61010-2-040 | Met requirements |
| 4 | Sterilizer complies with EMI/EMC requirements of FCC 47CFR, part 18, subpart B, and IEC 613261 | Met requirements |
| 5 | A Fault Tree Analysis and Mitigation (FTA-MIT) analysis have been preformed on the sterilizer and potential hazards were identified and mitigations were implemented among the control software safeties and design features | Met requirements |
| 6 | A Failure Mode Effects and Criticality Analysis (FMECA) was done for each component of the sterilizer and safeties were included in the design of the device according to the findings of this study (built-in safeties) | Met requirements |
| 7 | The amount of hydrogen peroxide and ozone remaining on containers and pouches immediately after cycle is not significant | Met requirements |
| 8 | There are no toxic residue or by-products residues remaining in/on medical product after the sterilization cycle is completed. After the cycle is completed, medical devices are cool to touch and ready to use immediately (no aeration is required) | Met requirements |
| 9 | The sterilization process is safe from an occupational safety point of view | Met requirements |
12
Substantial equivalence
The STERIZONE® VP4 Sterilizer ("VP4") is substantially equivalent to the STERRAD® 100NX® Sterilizer with DUO Cycle (K111377) and STERIS (Amsco®) V-PRO® maX Low Temperature Sterilization System (K131120). Table 4 summarizes the general specifications, indications, and overall technological characteristics for both the VP4 and predicate devices.
Table 4. General comparison of technical specifications, technology, and indications for the subject device and predicate devices.
| | Subject Device:
STERIZONE® VP4 | Predicate Device:
STERRAD 100NX
K111377 | Predicate Device:
STERIS V-PRO maX
K131120 |
|---------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | Terminal sterilization of reusable medical devices in health care facilities | Same | Same |
| General
Indications for
Use | The STERIZONE® VP4
Sterilizer is intended for
use in terminal
sterilization of cleaned,
rinsed, and dried metal
and non-metal reusable
medical devices in health
care facilities. | The STERRAD® 100NX®
Sterilizer is designed for
sterilization of both metal
and nonmetal medical
devices at low
temperatures. The
STERRAD sterilization
process is a multiphase
sterilization process that
utilizes a combination of
exposure to hydrogen
peroxide vapor and
plasma to safely sterilize
medical instruments and
materials without leaving
toxic residue. | The Amsco V-PRO maX
Low Temperature
Sterilization System, with
VAPROX® HC Steriant, is
a vaporized hydrogen
peroxide sterilizer
intended for use in the
terminal sterilization of
cleaned, rinsed, and dried
reusable metal and non-
metal medical devices
used in health care
facilities. |
| Sterilant | Vaporized Hydrogen
Peroxide / Ozone | Vaporized Hydrogen
Peroxide | Vaporized Hydrogen
Peroxide |
| H2O2
Concentration by
Weight | 50% | 59-94%
Depending on Cycle | 59% |
| Post H2O2
injection step | Ozone injection / Dwell | Air pulse / Dwell / Plasma | Air pulse / Dwell |
| Number Pulses | 2 | 2 | 4 |
| | Subject Device:
STERIZONE® VP4
Image: STERIZONE VP4 | Predicate Device:
STERRAD 100NX
K111377
Image: STERRAD 100NX | Predicate Device:
STERIS V-PRO maX
K131120
Image: STERIS V-PRO maX |
| Dimensions | H: 75.5 in (191.8 cm)
W: 30.5 in (77.5 cm)
D: 48.6 in (123.5 cm) | H: 70.5 in (179.1 cm)
W: 30.5 in (77.5 cm)
D: 40.0 in (102 cm) | H: 75.1 in (190.8 cm)
W: 33.0 in (83.8 cm)
D: 37.6 in (95.4 cm) |
| Weight | 1,245 lb (565 kg) | 938-1,006 lb (425-457 kg) | 788-910 lb (357-413 kg) |
| Chamber Volume | 125 L | 152 L | 136 L |
| Equipment
Operating
Temperature | 20-26 °C
Same as Load Temp | 18-35 °C (64-95 °F) | 5-40°C (41-104 °F) |
| Chamber (Wall)
Temperature | 41 °C |